- Home
- INLF vs KZR Comparison
INLF vs KZR Comparison
Compare INLF & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INLF | KZR |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | China | United States |
| Employees | 156 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.6M | 54.2M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | INLF | KZR |
|---|---|---|
| Price | $3.58 | $7.29 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 20.2K | ★ 143.4K |
| Earning Date | 03-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $3.53 |
| 52 Week High | $5.20 | $7.55 |
Technical Indicators
Market Signals| Indicator | INLF | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 54.64 |
| Support Level | $0.46 | $7.25 |
| Resistance Level | $4.68 | $7.47 |
| Average True Range (ATR) | 0.26 | 0.11 |
| MACD | -0.13 | -0.02 |
| Stochastic Oscillator | 0.00 | 37.50 |
Price Performance
Historical ComparisonAbout INLF INLIF LIMITED
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. Its portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.